ImageneBio, Inc. (NASDAQ:IMA)
| Market Cap | 49.74M-46.7% |
| Revenue (ttm) | 0-100.0% |
| Net Income | -52.48M-86.1% |
| EPS | -5.21+75.1% |
| Shares Out | 11.28M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,390.512 |
| Open | 4.48 |
| Previous Close | 4.61 |
| Day's Range | 4.41 - 4.59 |
| 52-Week Range | 3.94 - 9.10 |
| Beta | 0.74 |
| Analysts | Buy |
| Price Target | 1.33(-69.84%) |
| Earnings Date | Nov 11, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About IMA
ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$IMA stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in IMA holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by IMA's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
IMA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New IMA patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to IMA from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in IMA
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $1.35M |
| VXFVanguard Extended Market ETF | $267.58K |
| IWCiShares Micro-Cap ETF | $116.38K |
Estimated from each fund’s disclosed top holdings × AUM
IMA Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from IMA’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score